| Authors: |
Higashi-Kuwata N; Department of Refractory Viral Diseases, National Institute of Global Health and Medicine, Japan Institute for Health Security, Shinjuku-Ku, Tokyo 162-8655, Japan. Electronic address: kuwata.n@jihs.go.jp., Kato M; Department of Refractory Viral Diseases, National Institute of Global Health and Medicine, Japan Institute for Health Security, Shinjuku-Ku, Tokyo 162-8655, Japan., Hattori SI; Department of Refractory Viral Diseases, National Institute of Global Health and Medicine, Japan Institute for Health Security, Shinjuku-Ku, Tokyo 162-8655, Japan., Takamatsu Y; Department of Refractory Viral Diseases, National Institute of Global Health and Medicine, Japan Institute for Health Security, Shinjuku-Ku, Tokyo 162-8655, Japan., Mitsuya H; Department of Refractory Viral Diseases, National Institute of Global Health and Medicine, Japan Institute for Health Security, Shinjuku-Ku, Tokyo 162-8655, Japan; Kumamoto University Hospital, Kumamoto, 860-8556, Japan; Experimental Retrovirology Section, National Cancer Institute, NIH, Bethesda, MD, USA. Electronic address: hiroaki.mitsuya2@nih.gov. |
